Update your settings

Recent Entries

• Clinical Guidelines for Medication Use During Breastfeeding and Classification of High-Risk Drugs Requiring Cessation of Breastf

  by DengYue Medicine Jun 25

    In recent years, as public awareness of maternal and infant health continues to grow, medication safety during breastfeeding has become one of the primary concerns for new mothers. Many people believe that "no medications should be taken while breastfeeding," choosing to endure illness w...
• How to Choose Type 2 Diabetes Medications? A Stage-by-Stage Treatment Guide

  by DengYue Medicine Jun 25

    As the global prevalence of Type 2 Diabetes Mellitus (T2DM) continues to rise, choosing the right glucose-lowering medication has become one of the most important concerns for patients and their families. With so many treatment options available today, common questions include: ●&nbs...
• Antibiotics Are Not a Cure-All: These Common Infections Usually Do Not Require Them

  by DengYue Medicine Jun 25

    The discovery of antibiotics transformed the course of modern medicine. Many once-deadly infections became treatable, significantly increasing human life expectancy. However, as antibiotic use has become more widespread, a new challenge has emerged—antimicrobial resistance (AMR). ...
• MegaStream AI Drug Discovery Super Factory Launched in Shanghai: China Advances Industrialization of Complex Biologics R&D

  by DengYue Medicine Jun 18

  On June 15, in Shanghai, China, a new AI-driven pharmaceutical R&D platform—MegaStream TechBio—was officially launched. It is a next-generation AI-powered drug discovery platform jointly initiated by HBM Holdings and BioMap. This platform marks the transition of AI drug discover...
• Why the Global Boom in GLP-1 Weight Loss Drugs Makes Counterfeit Risks Impossible to Ignore

  by DengYue Medicine May 27

    In recent years, GLP-1 weight loss drugs have rapidly swept across the global market. From Semaglutide, originally developed for diabetes treatment, to the widely discussed Tirzepatide, and even Retatrutide, which is still generating major excitement in research pipelines, weight loss dr...
• Long-Acting Therapies Gain Momentum! Ruxolitinib Extended-Release Tablets Offer a New Option for Patients with Myelofibrosis

  by DengYue Medicine May 22

    In recent years, the treatment landscape for hematologic malignancies has gradually shifted from simple “disease control” toward an era of “long-term chronic disease management.” Especially for diseases such as myelofibrosis (MF), which often require prolonged or ...
• Application Prospects of the New Oral Tablet Baxdrostat in Resistant Hypertension

  by DengYue Medicine May 20

    On May 18, 2026, AstraZeneca announced that its first-in-class hypertension drug baxdrostat (brand name: Baxfendy) had officially received approval from the U.S. Food and Drug Administration (FDA). Baxdrostat is the first and currently the only approved aldosterone synthase inhibitor, in...
• A New Option in Targeted Biologic Therapy: Clinical Insights into Guselkumab Injection

  by DengYue Medicine May 19

    As a targeted biologic therapy, Tremfya offers a new treatment option for patients who have shown inadequate response or intolerance to conventional therapies, supported by its unique mechanism of action and extensive clinical data. The following overview examines its mechanism, approved...
• What Is Lupus? Why Is It Called the “Undying Cancer”?

  by DengYue Medicine May 12

    Systemic lupus erythematosus (SLE), commonly known as lupus, is a chronic autoimmune disease and one of the most common rheumatic immune disorders. In simple terms, the body’s immune system mistakenly attacks its own healthy tissues and organs, leading to chronic inflammation and m...
• Trouble Breathing? Don’t Ignore COPD: Why Pulmonary Function Testing Is the “Gold Standard” for Diagnosis

  by DengYue Medicine May 11

    Chronic obstructive pulmonary disease (COPD), commonly known as chronic obstructive lung disease, is a common yet often overlooked chronic respiratory condition. Many patients initially experience only mild symptoms such as shortness of breath when climbing stairs or feeling breathless w...
• My Experience with Mazdutide Injection for Weight Control: Shedding Pounds and Gaining Confidence with DengYueMed

  by DengYue Medicine November 29, 2025

  Hey everyone, I'm Sarah, a 35-year-old mom of two who's been on a rollercoaster with my weight for years. Like many of you, I've tried everything from fad diets to intense workout regimes, but nothing stuck long-term. That all changed when I discovered Mazdutide injection for weight control. I want ...